Which biotechs are the hottest acquisition targets heading into 2021 – and which large drugmakers are likely to seek to acquire them? Seventy-eight members of the biopharma investment community offered their opinions in a recent Bloomberg Intelligence survey – and today’s article outlines their biotech acquisition predictions. For more, CLICK HERE.
The Hottest Biotech Acquisition Targets For 2021 – And Who’s Likely To Target Them
Tags:2021 InvestingAcquisition TargetsBiopharma Investment CommunityBiotech Acquisition PredictionsBiotech StocksBloomberg Intelligence SurveyinvestorStock Market